None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Normal physical examination results before medication
Exclusion criteria
Exclusion criteria: Presence of severe systemic diseases or other severe oral mucous diseases or under cancer treatment Previous history of photobiomodulation therapy History of anti-inflammatory drugs treatment within a month Presence of lichenoid reaction caused by amalgam fillings or drugs known to cause drug induced lichenoid reaction Pregnancy intention of pregnancy lactation or recent use of steroid hormone based contraceptives OLP patients with skin lesions History of psychiatric disorders Participation in any other clinical trials in the 3 months before enrollment in this study Those lesions with epithelial dysplasia in histopathological evaluation Patient who are allergic to the drugs used in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in pain severity measured using the Visual Analog Scale and reduction in lesion severity assessed using the REU score that is Reticulation Erythema UlcerationTimepoint: At baseline 2 weeks 4 weeks after 1 month | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Kerala university of health sciences